Oryzon to present at upcoming international conferences

MADRID, SPAIN and CAMBRIDGE MA.

• Gordon Research Conference of “Neurobiology of Brain Disorders” in Barcelona (Spain)

• Solebury Trout 8th Annual Hamptons CEO Roundtable in Bridgehampton, USA

Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international conferences in August.

Click here to see the full Press Release